GlycoMimetics Ownership | Who Owns GlycoMimetics?

Overview Forecast RevenueFinancials Chart Transcripts

GlycoMimetics Ownership Summary

GlycoMimetics is owned by 27.57% institutional investors, 3.12% insiders, and 69.31% retail investors. Bvf inc/il is the largest institutional shareholder, holding 14.81% of GLYC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.99% of its assets in GlycoMimetics shares.

GLYC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	GlycoMimetics	27.57%	3.12%	69.31%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	9.54M	14.81%	$2.69M
Artal group	8.59M	13.33%	$2.42M
Vanguard group	2.70M	4.18%	$759.45K
Renaissance	826.85K	1.28%	$232.84K
Goldman sachs group	804.34K	1.25%	$226.50K
Blackrock	723.18K	1.12%	$203.65K
Acadian asset management	534.75K	0.83%	$150.00K
Geode capital management	487.24K	0.76%	$137.24K
Millennium management	186.23K	0.29%	$52.44K
State street	179.26K	0.28%	$50.48K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bvf inc/il	9.54M	0.08%	$2.69M
Artal group	8.59M	0.06%	$2.42M
Adar1 capital management	135.00K	0.01%	$38.02K
Intellectus partners	45.97K	0.00%	$12.94K
Torno capital	74.70K	0.00%	$21.04K
Tobias financial advisors	15.00K	0.00%	$4.22K
Bridgeway capital management	81.80K	0.00%	$23.04K
Acadian asset management	534.75K	0.00%	$150.00K
Renaissance	826.85K	0.00%	$232.84K
Two sigma advisers, lp	108.80K	0.00%	$30.64K

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	826.85K	0.00%	685.15K
Acadian asset management	534.75K	0.00%	204.23K
Ubs group	83.02K	-	81.52K
Two sigma advisers, lp	108.80K	0.00%	79.50K
Torno capital	74.70K	0.00%	74.70K

Top Sellers

Holder	Shares	% Assets	Change
Nea management company	-	-	-3.84M
Octagon capital advisors lp	-	-	-3.00M
Axa	-	-	-1.59M
Millennium management	186.23K	-	-560.73K
Susquehanna group, llp	-	-	-554.59K

New Positions

Holder	Shares	% Assets	Change	Value
Torno capital	74.70K	0.00%	74.70K	$21.04K
Eversource wealth advisors	4.75K	0.00%	4.75K	$1.03K

Sold Out

Holder	Change
Fmr	-67.00
Wells fargo & company/mn	-383.00
Old point trust & financial services n a	-500.00
National bank of canada /fi/	-600.00
Qube research	-1.10K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	33	-19.51%	17,775,290	-30.46%	27	1.75%	14	16.67%	11	-38.89%
Jun 30, 2024	41	-49.38%	25,560,030	-30.64%	39	1.21%	12	-75.51%	18	100.00%
Mar 31, 2024	81	32.79%	36,848,906	4.98%	57	1.92%	49	81.48%	9	-35.71%
Dec 31, 2023	61	24.49%	35,101,664	1.11%	54	1.87%	27	107.69%	14	-22.22%
Sep 30, 2023	49	-12.50%	34,716,628	-2.43%	54	1.55%	13	-7.14%	18	-5.26%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.93M	2.99%	-
Vanguard Institutional Extnd Mkt Idx Tr	730.60K	1.13%	-
MEDICAL BioHealth EUR Acc	609.48K	0.95%	-
Fidelity Extended Market Index	304.68K	0.47%	40.39K
iShares Micro-Cap ETF	112.96K	0.18%	-
BlackRock Extended Equity Market K	107.17K	0.17%	-46.00
Fidelity Total Market Index	80.84K	0.13%	-
Bridgeway Ultra-Small Company Market	76.40K	0.12%	-86.80K
Fidelity Series Total Market Index	64.46K	0.10%	-
NT Ext Equity Mkt Idx Fd - NL	51.98K	0.08%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 08, 2024	Invus Public Equities, L.P.	-	Sell	$50.01K
Aug 07, 2024	Invus Public Equities, L.P.	-	Sell	$11.20K
Aug 05, 2024	Invus Public Equities, L.P.	-	Sell	$31.00K
Aug 06, 2024	Invus Public Equities, L.P.	-	Sell	$10.19K
Aug 01, 2024	Invus Public Equities, L.P.	-	Sell	$13.74K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	9
2024 Q2	3	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	2	-

GLYC Ownership FAQ

Who Owns GlycoMimetics?

GlycoMimetics shareholders are primarily institutional investors at 27.57%, followed by 3.12% insiders and 69.31% retail investors. The average institutional ownership in GlycoMimetics's industry, Biotech Stocks , is 47.04%, which GlycoMimetics falls below.

Who owns the most shares of GlycoMimetics?

GlycoMimetics’s largest shareholders are Bvf inc/il (9.54M shares, 14.81%), Artal group (8.59M shares, 13.33%), and Vanguard group (2.7M shares, 4.18%). Together, they hold 32.32% of GlycoMimetics’s total shares outstanding.

Does Blackrock own GlycoMimetics?

Yes, BlackRock owns 1.12% of GlycoMimetics, totaling 723.18K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 203.65K$. In the last quarter, BlackRock decreased its holdings by -9.383K shares, a -1.28% change.

Who is GlycoMimetics’s biggest shareholder by percentage of total assets invested?

Bvf inc/il is GlycoMimetics’s biggest shareholder by percentage of total assets invested, with 0.08% of its assets in 9.54M GlycoMimetics shares, valued at 2.69M$.

Who is the top mutual fund holder of GlycoMimetics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of GlycoMimetics shares, with 2.99% of its total shares outstanding invested in 1.93M GlycoMimetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools